APO Research
Talk to an analyst

APO RESEARCH · REPORT

Multi-cancer Early Detection (MCED) Tests

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Multi-cancer Early Detection (MCED) Tests Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

15 April 2026195 pages

Choose your research edition.

Industry ResearchMulti-cancer Early Detection (MCED) Tests Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Multi-cancer Early Detection (MCED) Tests Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Multi-cancer Early Detection (MCED) Tests Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Multi-cancer Early Detection (MCED) Tests Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Multi-cancer Early Detection (MCED) Tests Market Analysis and Forecast 2026-2032239 pages · $4,950 USD

Market perspective

The global Multi-cancer Early Detection (MCED) Tests market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Multi-cancer Early Detection (MCED) Tests is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Multi-cancer Early Detection (MCED) Tests is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Multi-cancer Early Detection (MCED) Tests is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Multi-cancer Early Detection (MCED) Tests is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Multi-cancer Early Detection (MCED) Tests include Guardant Health, Exact Sciences, Freenome, Epiginomics AG, Bio-techne, ThriveEarlier Detection, GRAIL, Inc., CellMax life and Berry Genomics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Multi-cancer Early Detection (MCED) Tests market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Multi-cancer Early Detection (MCED) Tests and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Multi-cancer Early Detection (MCED) Tests revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Multi-cancer Early Detection (MCED) Tests market size, projected growth trends, production technologies, key applications, and end-use industries.

Multi-cancer Early Detection (MCED) Tests Segment by Company

Guardant Health

Exact Sciences

Freenome

Epiginomics AG

Bio-techne

ThriveEarlier Detection

GRAIL, Inc.

CellMax life

Berry Genomics

Singlera Genomics

Geneseeq

BGI Genomics

Burning Rock Biotech Limited

New Horizon Health Limited

Yeasen Bio

Hangzhou Aoru Biotech

Amoy Diagnostics Co., Ltd.

Genetron Health

AnchorDx

Surexam Bio-Tech Co.,Ltd.

HaploX

HefeiLaierBiotechnologyCo.,Ltd

Multi-cancer Early Detection (MCED) Tests Segment by Type

ctDNA Detection

CTC Detection

Exosome Detection

Multi-cancer Early Detection (MCED) Tests Segment by Application

Medical Institutions

Physical Examination Centers

Multi-cancer Early Detection (MCED) Tests Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multi-cancer Early Detection (MCED) Tests market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Multi-cancer Early Detection (MCED) Tests and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multi-cancer Early Detection (MCED) Tests.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Multi-cancer Early Detection (MCED) Tests in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Multi-cancer Early Detection (MCED) Tests industry.

Chapter 3: Detailed analysis of Multi-cancer Early Detection (MCED) Tests companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Multi-cancer Early Detection (MCED) Testsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of ctDNA Detection Table 3. Key Players of CTC Detection Table 4. Key Players of Exosome Detection Table 4. Global Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Medical Institutions Table 6. Key Players of Physical Examination Centers Table 7. Global Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Multi-cancer Early Detection (MCED) Tests Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Multi-cancer Early Detection (MCED) Tests Market Share by Region (2021-2026) Table 10. Global Multi-cancer Early Detection (MCED) Tests Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Multi-cancer Early Detection (MCED) Tests Market Share by Region (2027-2032) Table 12. Multi-cancer Early Detection (MCED) Tests Industry Trends Table 13. Multi-cancer Early Detection (MCED) Tests Industry Drivers Table 14. Multi-cancer Early Detection (MCED) Tests Industry Opportunities and Challenges Table 15. Multi-cancer Early Detection (MCED) Tests Industry Restraints Table 16. Global Multi-cancer Early Detection (MCED) Tests Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Multi-cancer Early Detection (MCED) Tests Revenue Market Share by Company (2021-2026) Table 18. Global Multi-cancer Early Detection (MCED) Tests Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Multi-cancer Early Detection (MCED) Tests Key Company Head Office and Area Served Table 20. Global Multi-cancer Early Detection (MCED) Tests Company, Product Type & Application Table 21. Global Multi-cancer Early Detection (MCED) Tests Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Multi-cancer Early Detection (MCED) Tests by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Multi-cancer Early Detection (MCED) Tests Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Multi-cancer Early Detection (MCED) Tests Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Multi-cancer Early Detection (MCED) Tests Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Multi-cancer Early Detection (MCED) Tests Revenue Market Share by Type (2021-2026) Table 28. Global Multi-cancer Early Detection (MCED) Tests Revenue Market Share by Type (2027-2032) Table 29. Global Multi-cancer Early Detection (MCED) Tests Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Multi-cancer Early Detection (MCED) Tests Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Multi-cancer Early Detection (MCED) Tests Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Multi-cancer Early Detection (MCED) Tests Revenue Market Share by Application (2021-2026) Table 33. Global Multi-cancer Early Detection (MCED) Tests Revenue Market Share by Application (2027-2032) Table 34. Guardant Health Company Information Table 35. Guardant Health Business Overview Table 36. Guardant Health Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Guardant Health Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 38. Guardant Health Recent Development Table 39. Exact Sciences Company Information Table 40. Exact Sciences Business Overview Table 41. Exact Sciences Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Exact Sciences Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 43. Exact Sciences Recent Development Table 44. Freenome Company Information Table 45. Freenome Business Overview Table 46. Freenome Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Freenome Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 48. Freenome Recent Development Table 49. Epiginomics AG Company Information Table 50. Epiginomics AG Business Overview Table 51. Epiginomics AG Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Epiginomics AG Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 53. Epiginomics AG Recent Development Table 54. Bio-techne Company Information Table 55. Bio-techne Business Overview Table 56. Bio-techne Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Bio-techne Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 58. Bio-techne Recent Development Table 59. ThriveEarlier Detection Company Information Table 60. ThriveEarlier Detection Business Overview Table 61. ThriveEarlier Detection Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. ThriveEarlier Detection Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 63. ThriveEarlier Detection Recent Development Table 64. GRAIL, Inc. Company Information Table 65. GRAIL, Inc. Business Overview Table 66. GRAIL, Inc. Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. GRAIL, Inc. Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 68. GRAIL, Inc. Recent Development Table 69. CellMax life Company Information Table 70. CellMax life Business Overview Table 71. CellMax life Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. CellMax life Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 73. CellMax life Recent Development Table 74. Berry Genomics Company Information Table 75. Berry Genomics Business Overview Table 76. Berry Genomics Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Berry Genomics Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 78. Berry Genomics Recent Development Table 79. Singlera Genomics Company Information Table 80. Singlera Genomics Business Overview Table 81. Singlera Genomics Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Singlera Genomics Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 83. Singlera Genomics Recent Development Table 84. Geneseeq Company Information Table 85. Geneseeq Business Overview Table 86. Geneseeq Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Geneseeq Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 88. Geneseeq Recent Development Table 89. BGI Genomics Company Information Table 90. BGI Genomics Business Overview Table 91. BGI Genomics Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. BGI Genomics Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 93. BGI Genomics Recent Development Table 94. Burning Rock Biotech Limited Company Information Table 95. Burning Rock Biotech Limited Business Overview Table 96. Burning Rock Biotech Limited Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Burning Rock Biotech Limited Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 98. Burning Rock Biotech Limited Recent Development Table 99. New Horizon Health Limited Company Information Table 100. New Horizon Health Limited Business Overview Table 101. New Horizon Health Limited Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. New Horizon Health Limited Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 103. New Horizon Health Limited Recent Development Table 104. Yeasen Bio Company Information Table 105. Yeasen Bio Business Overview Table 106. Yeasen Bio Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Yeasen Bio Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 108. Yeasen Bio Recent Development Table 109. Hangzhou Aoru Biotech Company Information Table 110. Hangzhou Aoru Biotech Business Overview Table 111. Hangzhou Aoru Biotech Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Hangzhou Aoru Biotech Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 113. Hangzhou Aoru Biotech Recent Development Table 114. Amoy Diagnostics Co., Ltd. Company Information Table 115. Amoy Diagnostics Co., Ltd. Business Overview Table 116. Amoy Diagnostics Co., Ltd. Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 117. Amoy Diagnostics Co., Ltd. Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 118. Amoy Diagnostics Co., Ltd. Recent Development Table 119. Genetron Health Company Information Table 120. Genetron Health Business Overview Table 121. Genetron Health Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 122. Genetron Health Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 123. Genetron Health Recent Development Table 124. AnchorDx Company Information Table 125. AnchorDx Business Overview Table 126. AnchorDx Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 127. AnchorDx Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 128. AnchorDx Recent Development Table 129. Surexam Bio-Tech Co.,Ltd. Company Information Table 130. Surexam Bio-Tech Co.,Ltd. Business Overview Table 131. Surexam Bio-Tech Co.,Ltd. Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 132. Surexam Bio-Tech Co.,Ltd. Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 133. Surexam Bio-Tech Co.,Ltd. Recent Development Table 134. HaploX Company Information Table 135. HaploX Business Overview Table 136. HaploX Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 137. HaploX Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 138. HaploX Recent Development Table 139. HefeiLaierBiotechnologyCo.,Ltd Company Information Table 140. HefeiLaierBiotechnologyCo.,Ltd Business Overview Table 141. HefeiLaierBiotechnologyCo.,Ltd Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 142. HefeiLaierBiotechnologyCo.,Ltd Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 143. HefeiLaierBiotechnologyCo.,Ltd Recent Development Table 144. North America Multi-cancer Early Detection (MCED) Tests Market Size by Type (2021-2026) & (US$ Million) Table 145. North America Multi-cancer Early Detection (MCED) Tests Market Size by Type (2027-2032) & (US$ Million) Table 146. North America Multi-cancer Early Detection (MCED) Tests Market Size by Application (2021-2026) & (US$ Million) Table 147. North America Multi-cancer Early Detection (MCED) Tests Market Size by Application (2027-2032) & (US$ Million) Table 148. North America Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. North America Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021-2026) Table 150. North America Multi-cancer Early Detection (MCED) Tests Market Size by Country (2027-2032) Table 151. Europe Multi-cancer Early Detection (MCED) Tests Market Size by Type (2021-2026) & (US$ Million) Table 152. Europe Multi-cancer Early Detection (MCED) Tests Market Size by Type (2027-2032) & (US$ Million) Table 153. Europe Multi-cancer Early Detection (MCED) Tests Market Size by Application (2021-2026) & (US$ Million) Table 154. Europe Multi-cancer Early Detection (MCED) Tests Market Size by Application (2027-2032) & (US$ Million) Table 155. Europe Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. Europe Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021-2026) Table 157. Europe Multi-cancer Early Detection (MCED) Tests Market Size by Country (2027-2032) Table 158. China Multi-cancer Early Detection (MCED) Tests Market Size by Type (2021-2026) & (US$ Million) Table 159. China Multi-cancer Early Detection (MCED) Tests Market Size by Type (2027-2032) & (US$ Million) Table 160. China Multi-cancer Early Detection (MCED) Tests Market Size by Application (2021-2026) & (US$ Million) Table 161. China Multi-cancer Early Detection (MCED) Tests Market Size by Application (2027-2032) & (US$ Million) Table 162. Asia Multi-cancer Early Detection (MCED) Tests Market Size by Type (2021-2026) & (US$ Million) Table 163. Asia Multi-cancer Early Detection (MCED) Tests Market Size by Type (2027-2032) & (US$ Million) Table 164. Asia Multi-cancer Early Detection (MCED) Tests Market Size by Application (2021-2026) & (US$ Million) Table 165. Asia Multi-cancer Early Detection (MCED) Tests Market Size by Application (2027-2032) & (US$ Million) Table 166. Asia Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. Asia Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021-2026) Table 168. Asia Multi-cancer Early Detection (MCED) Tests Market Size by Country (2027-2032) Table 169. South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size by Type (2021-2026) & (US$ Million) Table 170. South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size by Type (2027-2032) & (US$ Million) Table 171. South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size by Application (2021-2026) & (US$ Million) Table 172. South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size by Application (2027-2032) & (US$ Million) Table 173. South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021-2026) Table 175. South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size by Country (2027-2032) Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Multi-cancer Early Detection (MCED) Tests Product Image Figure 2. Global Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Multi-cancer Early Detection (MCED) Tests Market Share by Type: 2025 VS 2032 Figure 4. ctDNA Detection Image Figure 5. CTC Detection Image Figure 6. Exosome Detection Image Figure 7. Global Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Multi-cancer Early Detection (MCED) Tests Market Share by Application: 2025 VS 2032 Figure 9. Medical Institutions Image Figure 10. Physical Examination Centers Image Figure 11. Global Multi-cancer Early Detection (MCED) Tests Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 13. Global Multi-cancer Early Detection (MCED) Tests Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Multi-cancer Early Detection (MCED) Tests Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Multi-cancer Early Detection (MCED) Tests Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Multi-cancer Early Detection (MCED) Tests Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Multi-cancer Early Detection (MCED) Tests Revenue Market Share by Type (2021-2032) Figure 20. Global Multi-cancer Early Detection (MCED) Tests Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Multi-cancer Early Detection (MCED) Tests Revenue Market Share by Application (2021-2032) Figure 22. North America Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 23. North America Multi-cancer Early Detection (MCED) Tests Market Share by Type (2021-2032) Figure 24. North America Multi-cancer Early Detection (MCED) Tests Market Share by Application (2021-2032) Figure 25. North America Multi-cancer Early Detection (MCED) Tests Market Share by Country (2021-2032) Figure 26. United States Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 27. Canada Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 29. Europe Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 30. Europe Multi-cancer Early Detection (MCED) Tests Market Share by Type (2021-2032) Figure 31. Europe Multi-cancer Early Detection (MCED) Tests Market Share by Application (2021-2032) Figure 32. Europe Multi-cancer Early Detection (MCED) Tests Market Share by Country (2021-2032) Figure 33. Germany Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 34. France Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 36. Italy Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 37. Russia Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 39. China Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 40. China Multi-cancer Early Detection (MCED) Tests Market Share by Type (2021-2032) Figure 41. China Multi-cancer Early Detection (MCED) Tests Market Share by Application (2021-2032) Figure 42. Asia Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 43. Asia Multi-cancer Early Detection (MCED) Tests Market Share by Type (2021-2032) Figure 44. Asia Multi-cancer Early Detection (MCED) Tests Market Share by Application (2021-2032) Figure 45. Asia Multi-cancer Early Detection (MCED) Tests Market Share by Country (2021-2032) Figure 46. Japan Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 50. India Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 51. Australia Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Share by Country (2021-2032) Figure 56. Brazil Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 61. UAE Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 63. Chile Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • ctDNA Detection
  • CTC Detection
  • Exosome Detection
Applications
  • Medical Institutions
  • Physical Examination Centers
Companies covered
  • Guardant Health
  • Exact Sciences
  • Freenome
  • Epiginomics AG
  • Bio-techne
  • ThriveEarlier Detection
  • GRAIL, Inc.
  • CellMax life
  • Berry Genomics
  • Singlera Genomics
  • Geneseeq
  • BGI Genomics
  • Burning Rock Biotech Limited
  • New Horizon Health Limited
  • Yeasen Bio
  • Hangzhou Aoru Biotech
  • Amoy Diagnostics Co., Ltd.
  • Genetron Health
  • AnchorDx
  • Surexam Bio-Tech Co.,Ltd.
  • HaploX
  • HefeiLaierBiotechnologyCo.,Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 ctDNA Detection
  5. 1.2.3 CTC Detection
  6. 1.2.4 Exosome Detection
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Medical Institutions
  10. 1.3.3 Physical Examination Centers
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Multi-cancer Early Detection (MCED) Tests Growth Trends by Region
  13. 1.5.1 Global Multi-cancer Early Detection (MCED) Tests Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Multi-cancer Early Detection (MCED) Tests Market Size by Region (2021-2026)
  15. 1.5.3 Multi-cancer Early Detection (MCED) Tests Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Multi-cancer Early Detection (MCED) Tests Market Dynamics
  1. 2.1 Multi-cancer Early Detection (MCED) Tests Industry Trends
  2. 2.2 Multi-cancer Early Detection (MCED) Tests Industry Drivers
  3. 2.3 Multi-cancer Early Detection (MCED) Tests Industry Opportunities and Challenges
  4. 2.4 Multi-cancer Early Detection (MCED) Tests Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Multi-cancer Early Detection (MCED) Tests Revenue by Company (2021-2026)
  2. 3.2 Global Multi-cancer Early Detection (MCED) Tests Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Multi-cancer Early Detection (MCED) Tests Key Company Head office and Area Served
  4. 3.4 Global Multi-cancer Early Detection (MCED) Tests Company, Product Type & Application
  5. 3.5 Global Multi-cancer Early Detection (MCED) Tests Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Multi-cancer Early Detection (MCED) Tests Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Multi-cancer Early Detection (MCED) Tests Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Multi-cancer Early Detection (MCED) Tests Tier 1, Tier 2, and Tier 3
4 Multi-cancer Early Detection (MCED) Tests Market by Type
  1. 4.1 Global Multi-cancer Early Detection (MCED) Tests Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Multi-cancer Early Detection (MCED) Tests Market Size by Type (2021-2032)
  3. 4.3 Global Multi-cancer Early Detection (MCED) Tests Market Size Share by Type (2021-2032)
5 Multi-cancer Early Detection (MCED) Tests Market by Application
  1. 5.1 Global Multi-cancer Early Detection (MCED) Tests Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Multi-cancer Early Detection (MCED) Tests Market Size by Application (2021-2032)
  3. 5.3 Global Multi-cancer Early Detection (MCED) Tests Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Guardant Health
  2. 6.1.1 Guardant Health Company Information
  3. 6.1.2 Guardant Health Business Overview
  4. 6.1.3 Guardant Health Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Guardant Health Multi-cancer Early Detection (MCED) Tests Product Portfolio
  6. 6.1.5 Guardant Health Recent Developments
  7. 6.2 Exact Sciences
  8. 6.2.1 Exact Sciences Company Information
  9. 6.2.2 Exact Sciences Business Overview
  10. 6.2.3 Exact Sciences Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Exact Sciences Multi-cancer Early Detection (MCED) Tests Product Portfolio
  12. 6.2.5 Exact Sciences Recent Developments
  13. 6.3 Freenome
  14. 6.3.1 Freenome Company Information
  15. 6.3.2 Freenome Business Overview
  16. 6.3.3 Freenome Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Freenome Multi-cancer Early Detection (MCED) Tests Product Portfolio
  18. 6.3.5 Freenome Recent Developments
  19. 6.4 Epiginomics AG
  20. 6.4.1 Epiginomics AG Company Information
  21. 6.4.2 Epiginomics AG Business Overview
  22. 6.4.3 Epiginomics AG Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Epiginomics AG Multi-cancer Early Detection (MCED) Tests Product Portfolio
  24. 6.4.5 Epiginomics AG Recent Developments
  25. 6.5 Bio-techne
  26. 6.5.1 Bio-techne Company Information
  27. 6.5.2 Bio-techne Business Overview
  28. 6.5.3 Bio-techne Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Bio-techne Multi-cancer Early Detection (MCED) Tests Product Portfolio
  30. 6.5.5 Bio-techne Recent Developments
  31. 6.6 ThriveEarlier Detection
  32. 6.6.1 ThriveEarlier Detection Company Information
  33. 6.6.2 ThriveEarlier Detection Business Overview
  34. 6.6.3 ThriveEarlier Detection Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 ThriveEarlier Detection Multi-cancer Early Detection (MCED) Tests Product Portfolio
  36. 6.6.5 ThriveEarlier Detection Recent Developments
  37. 6.7 GRAIL, Inc.
  38. 6.7.1 GRAIL, Inc. Company Information
  39. 6.7.2 GRAIL, Inc. Business Overview
  40. 6.7.3 GRAIL, Inc. Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 GRAIL, Inc. Multi-cancer Early Detection (MCED) Tests Product Portfolio
  42. 6.7.5 GRAIL, Inc. Recent Developments
  43. 6.8 CellMax life
  44. 6.8.1 CellMax life Company Information
  45. 6.8.2 CellMax life Business Overview
  46. 6.8.3 CellMax life Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 CellMax life Multi-cancer Early Detection (MCED) Tests Product Portfolio
  48. 6.8.5 CellMax life Recent Developments
  49. 6.9 Berry Genomics
  50. 6.9.1 Berry Genomics Company Information
  51. 6.9.2 Berry Genomics Business Overview
  52. 6.9.3 Berry Genomics Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Berry Genomics Multi-cancer Early Detection (MCED) Tests Product Portfolio
  54. 6.9.5 Berry Genomics Recent Developments
  55. 6.10 Singlera Genomics
  56. 6.10.1 Singlera Genomics Company Information
  57. 6.10.2 Singlera Genomics Business Overview
  58. 6.10.3 Singlera Genomics Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Singlera Genomics Multi-cancer Early Detection (MCED) Tests Product Portfolio
  60. 6.10.5 Singlera Genomics Recent Developments
  61. 6.11 Geneseeq
  62. 6.11.1 Geneseeq Company Information
  63. 6.11.2 Geneseeq Business Overview
  64. 6.11.3 Geneseeq Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Geneseeq Multi-cancer Early Detection (MCED) Tests Product Portfolio
  66. 6.11.5 Geneseeq Recent Developments
  67. 6.12 BGI Genomics
  68. 6.12.1 BGI Genomics Company Information
  69. 6.12.2 BGI Genomics Business Overview
  70. 6.12.3 BGI Genomics Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 BGI Genomics Multi-cancer Early Detection (MCED) Tests Product Portfolio
  72. 6.12.5 BGI Genomics Recent Developments
  73. 6.13 Burning Rock Biotech Limited
  74. 6.13.1 Burning Rock Biotech Limited Company Information
  75. 6.13.2 Burning Rock Biotech Limited Business Overview
  76. 6.13.3 Burning Rock Biotech Limited Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Burning Rock Biotech Limited Multi-cancer Early Detection (MCED) Tests Product Portfolio
  78. 6.13.5 Burning Rock Biotech Limited Recent Developments
  79. 6.14 New Horizon Health Limited
  80. 6.14.1 New Horizon Health Limited Company Information
  81. 6.14.2 New Horizon Health Limited Business Overview
  82. 6.14.3 New Horizon Health Limited Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 New Horizon Health Limited Multi-cancer Early Detection (MCED) Tests Product Portfolio
  84. 6.14.5 New Horizon Health Limited Recent Developments
  85. 6.15 Yeasen Bio
  86. 6.15.1 Yeasen Bio Company Information
  87. 6.15.2 Yeasen Bio Business Overview
  88. 6.15.3 Yeasen Bio Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Yeasen Bio Multi-cancer Early Detection (MCED) Tests Product Portfolio
  90. 6.15.5 Yeasen Bio Recent Developments
  91. 6.16 Hangzhou Aoru Biotech
  92. 6.16.1 Hangzhou Aoru Biotech Company Information
  93. 6.16.2 Hangzhou Aoru Biotech Business Overview
  94. 6.16.3 Hangzhou Aoru Biotech Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Hangzhou Aoru Biotech Multi-cancer Early Detection (MCED) Tests Product Portfolio
  96. 6.16.5 Hangzhou Aoru Biotech Recent Developments
  97. 6.17 Amoy Diagnostics Co., Ltd.
  98. 6.17.1 Amoy Diagnostics Co., Ltd. Company Information
  99. 6.17.2 Amoy Diagnostics Co., Ltd. Business Overview
  100. 6.17.3 Amoy Diagnostics Co., Ltd. Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Amoy Diagnostics Co., Ltd. Multi-cancer Early Detection (MCED) Tests Product Portfolio
  102. 6.17.5 Amoy Diagnostics Co., Ltd. Recent Developments
  103. 6.18 Genetron Health
  104. 6.18.1 Genetron Health Company Information
  105. 6.18.2 Genetron Health Business Overview
  106. 6.18.3 Genetron Health Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Genetron Health Multi-cancer Early Detection (MCED) Tests Product Portfolio
  108. 6.18.5 Genetron Health Recent Developments
  109. 6.19 AnchorDx
  110. 6.19.1 AnchorDx Company Information
  111. 6.19.2 AnchorDx Business Overview
  112. 6.19.3 AnchorDx Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 AnchorDx Multi-cancer Early Detection (MCED) Tests Product Portfolio
  114. 6.19.5 AnchorDx Recent Developments
  115. 6.20 Surexam Bio-Tech Co.,Ltd.
  116. 6.20.1 Surexam Bio-Tech Co.,Ltd. Company Information
  117. 6.20.2 Surexam Bio-Tech Co.,Ltd. Business Overview
  118. 6.20.3 Surexam Bio-Tech Co.,Ltd. Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Surexam Bio-Tech Co.,Ltd. Multi-cancer Early Detection (MCED) Tests Product Portfolio
  120. 6.20.5 Surexam Bio-Tech Co.,Ltd. Recent Developments
  121. 6.21 HaploX
  122. 6.21.1 HaploX Company Information
  123. 6.21.2 HaploX Business Overview
  124. 6.21.3 HaploX Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 HaploX Multi-cancer Early Detection (MCED) Tests Product Portfolio
  126. 6.21.5 HaploX Recent Developments
  127. 6.22 HefeiLaierBiotechnologyCo.,Ltd
  128. 6.22.1 HefeiLaierBiotechnologyCo.,Ltd Company Information
  129. 6.22.2 HefeiLaierBiotechnologyCo.,Ltd Business Overview
  130. 6.22.3 HefeiLaierBiotechnologyCo.,Ltd Multi-cancer Early Detection (MCED) Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 HefeiLaierBiotechnologyCo.,Ltd Multi-cancer Early Detection (MCED) Tests Product Portfolio
  132. 6.22.5 HefeiLaierBiotechnologyCo.,Ltd Recent Developments
7 North America
  1. 7.1 North America Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032)
  2. 7.2 North America Multi-cancer Early Detection (MCED) Tests Market Size by Type
  3. 7.2.1 North America Multi-cancer Early Detection (MCED) Tests Market Size by Type (2021-2026)
  4. 7.2.2 North America Multi-cancer Early Detection (MCED) Tests Market Size by Type (2027-2032)
  5. 7.2.3 North America Multi-cancer Early Detection (MCED) Tests Market Share by Type (2021-2032)
  6. 7.3 North America Multi-cancer Early Detection (MCED) Tests Market Size by Application
  7. 7.3.1 North America Multi-cancer Early Detection (MCED) Tests Market Size by Application (2021-2026)
  8. 7.3.2 North America Multi-cancer Early Detection (MCED) Tests Market Size by Application (2027-2032)
  9. 7.3.3 North America Multi-cancer Early Detection (MCED) Tests Market Share by Application (2021-2032)
  10. 7.4 North America Multi-cancer Early Detection (MCED) Tests Market Size by Country
  11. 7.4.1 North America Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021-2026)
  13. 7.4.3 North America Multi-cancer Early Detection (MCED) Tests Market Size by Country (2027-2032)
  14. 7.4.4 North America Multi-cancer Early Detection (MCED) Tests Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032)
  2. 8.2 Europe Multi-cancer Early Detection (MCED) Tests Market Size by Type
  3. 8.2.1 Europe Multi-cancer Early Detection (MCED) Tests Market Size by Type (2021-2026)
  4. 8.2.2 Europe Multi-cancer Early Detection (MCED) Tests Market Size by Type (2027-2032)
  5. 8.2.3 Europe Multi-cancer Early Detection (MCED) Tests Market Share by Type (2021-2032)
  6. 8.3 Europe Multi-cancer Early Detection (MCED) Tests Market Size by Application
  7. 8.3.1 Europe Multi-cancer Early Detection (MCED) Tests Market Size by Application (2021-2026)
  8. 8.3.2 Europe Multi-cancer Early Detection (MCED) Tests Market Size by Application (2027-2032)
  9. 8.3.3 Europe Multi-cancer Early Detection (MCED) Tests Market Share by Application (2021-2032)
  10. 8.4 Europe Multi-cancer Early Detection (MCED) Tests Market Size by Country
  11. 8.4.1 Europe Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021-2026)
  13. 8.4.3 Europe Multi-cancer Early Detection (MCED) Tests Market Size by Country (2027-2032)
  14. 8.4.4 Europe Multi-cancer Early Detection (MCED) Tests Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032)
  2. 9.2 China Multi-cancer Early Detection (MCED) Tests Market Size by Type
  3. 9.2.1 China Multi-cancer Early Detection (MCED) Tests Market Size by Type (2021-2026)
  4. 9.2.2 China Multi-cancer Early Detection (MCED) Tests Market Size by Type (2027-2032)
  5. 9.2.3 China Multi-cancer Early Detection (MCED) Tests Market Share by Type (2021-2032)
  6. 9.3 China Multi-cancer Early Detection (MCED) Tests Market Size by Application
  7. 9.3.1 China Multi-cancer Early Detection (MCED) Tests Market Size by Application (2021-2026)
  8. 9.3.2 China Multi-cancer Early Detection (MCED) Tests Market Size by Application (2027-2032)
  9. 9.3.3 China Multi-cancer Early Detection (MCED) Tests Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032)
  2. 10.2 Asia Multi-cancer Early Detection (MCED) Tests Market Size by Type
  3. 10.2.1 Asia Multi-cancer Early Detection (MCED) Tests Market Size by Type (2021-2026)
  4. 10.2.2 Asia Multi-cancer Early Detection (MCED) Tests Market Size by Type (2027-2032)
  5. 10.2.3 Asia Multi-cancer Early Detection (MCED) Tests Market Share by Type (2021-2032)
  6. 10.3 Asia Multi-cancer Early Detection (MCED) Tests Market Size by Application
  7. 10.3.1 Asia Multi-cancer Early Detection (MCED) Tests Market Size by Application (2021-2026)
  8. 10.3.2 Asia Multi-cancer Early Detection (MCED) Tests Market Size by Application (2027-2032)
  9. 10.3.3 Asia Multi-cancer Early Detection (MCED) Tests Market Share by Application (2021-2032)
  10. 10.4 Asia Multi-cancer Early Detection (MCED) Tests Market Size by Country
  11. 10.4.1 Asia Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021-2026)
  13. 10.4.3 Asia Multi-cancer Early Detection (MCED) Tests Market Size by Country (2027-2032)
  14. 10.4.4 Asia Multi-cancer Early Detection (MCED) Tests Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst